NIH-funded research NIH-funded research

Investigating how a specific protein affects pancreatic cancer growth

Official title: The Role of Guanine Exchange Factors in Pancreatic Ductal Adenocarcinoma (PDAC)

Funded at Wayne State University · NIH-10987453 · Data updated 2026-11-12

This study is looking at how a protein called RCC1 affects the growth of pancreatic cancer, with the hope that understanding its role could help develop new treatments for patients facing this tough diagnosis.

More Adenocarcinoma research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$50,474
NIH project number1F99CA294132-01
Project IDNIH-10987453 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma.

Less likely to help

Patients with other types of cancer or those without pancreatic cancer may not benefit from this research.

What this research studies

This research focuses on pancreatic ductal adenocarcinoma (PDAC), a type of cancer known for its poor prognosis and limited treatment options. The study aims to understand the role of a protein called RCC1 in the growth and progression of PDAC by examining how it influences cellular processes and metabolism. Using advanced techniques like transcriptomics and metabolomics, researchers will explore how changes in RCC1 levels affect cancer cell behavior and survival. Patients may benefit from insights that could lead to new therapeutic strategies targeting this protein.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients with pancreatic cancer.

How similar studies have gone: While the specific role of RCC1 in PDAC is not fully understood, similar research approaches have shown promise in other cancer types.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Bannoura, Sahar — Wayne State University
  • Study coordinator: Bannoura, Sahar

Related research

Other NIH-funded projects on the same topics.

  • Investigating how a specific protein affects pancreatic cancer growth and spread

    This study is looking at a protein called RCC1 to see how it affects pancreatic cancer cells, with the hope that understanding its role could help develop new treatments for patients facing this tough disease.

    NIH research Wayne State University · Detroit, United States · NIH-11228868

  • AI to find early signs of pancreatic cancer on routine CT scans

    Uses artificial intelligence to look at routine abdominal CT scans and medical information to find people likely to develop pancreatic cancer within three years.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11172502

  • Using AI to predict pancreatic cancer risk in African Americans from CT scans

    This study is using advanced computer technology to look at CT scans and help find out which African Americans might be at higher risk for pancreatic cancer in the next ten years, so that doctors can catch it early and improve treatment options.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11014899

  • Using AI to predict pancreatic cancer risk from CT scans

    This study is looking to use artificial intelligence to help spot people who might be at high risk for pancreatic cancer by analyzing CT scans and other information, so that doctors can catch the disease early and improve chances of survival.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-10911178

  • Fibrin-rich tumor stroma as a new driver of immune response in pancreatic cancer

    This grant explores how fibrin-involved tumor surroundings in pancreatic cancer might affect immune therapy, with the goal of making treatments work better for patients.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11455114

  • TREM2+ macrophages and liver metastases in pancreatic cancer

    Researchers are studying immune cells in liver metastases from pancreatic cancer to understand how they influence the cancer’s spread and more effective treatments.

    NIH research Washington University · Saint Louis, United States · NIH-11452084

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.